This limited FDG avidity suggests that ILC rely less on glucose than other breast cancers; several studies to date support that ILC has a distinct metabolic phenotype [3-6], yet studies of how ILC may differentially utilize or rely on other fuels like fatty acids or amino acids are in their early stages. The gene discussed is CCL27; the disease is breast carcinoma.